Innovative vaccines for a healthier world|Bent U Frandsen, Chief Executive Officer,ExpreS2ion Biotech Holding 00:10:00
Mr. Frandsen is experienced in licensing, services, M&A, and new cash deals in excess of €200 million, and has furthermore been in charge of successfully closing numerous collaboration agreements pertaining to research and development of both new chemical entities and biologicals.